Đang chuẩn bị liên kết để tải về tài liệu:
PIK3CA mutation is a favorable prognostic factor in esophageal cancer: Molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Practical and reliable genotyping procedures with a considerable number of samples are required not only for risk-adapted therapeutic strategies, but also for stratifying patients into future clinical trials for moleculartargeting drugs. | PIK3CA mutation is a favorable prognostic factor in esophageal cancer Molecular profile by next-generation sequencing using surgically resected formalin-fixed paraffin-embedded tissue

TÀI LIỆU LIÊN QUAN

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: Pyrosequencing technology and literature review

Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer

PIK3CA amplification is common in left side tubular adenomas but uncommon sessile serrated adenomas exclusively with KRAS mutation

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients

Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow

Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.